mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-13 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-12 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-10 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-09 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-09 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-09 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-09 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |